A systematic review of validated methods for identifying atrial fibrillation using administrative data
Article first published online: 19 JAN 2012
Copyright © 2012 John Wiley & Sons, Ltd.
Pharmacoepidemiology and Drug Safety
Supplement: The U.S. Food and Drug Administration's Mini-Sentinel Program
Volume 21, Issue Supplement S1, pages 141–147, January 2012
How to Cite
Jensen, P. N., Johnson, K., Floyd, J., Heckbert, S. R., Carnahan, R. and Dublin, S. (2012), A systematic review of validated methods for identifying atrial fibrillation using administrative data. Pharmacoepidem. Drug Safe., 21: 141–147. doi: 10.1002/pds.2317
- Issue published online: 19 JAN 2012
- Article first published online: 19 JAN 2012
- Food and Drug Administration. Grant Numbers: HHSF223200910006I, NHLBI HL068986, T32HL007902
- Group Health Research Institute internal funds. Grant Number: NIA K23AG028954
- 3Food and Drug Administration. Listing of DMEs is adapted from “Safety Reporting Requirements for Human Drug and Biological Products; Proposed Rule”. Department of Health and Human Services, Washington, DCMarch 14, 2003. http://www.fda.gov/OHRMS/DOCKETS/98fr/03-5204.pdf [3 December 2010].
- 4The Observational Medical Outcomes Partnership (OMOP). Health Outcomes of Interest. Foundation for the National Institutes of Health, Bethesda http://omop.fnih.org/HOI [7 June 2010].
- 22ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006; 114: e257-354. DOI:114/7/e257 [pii]10.1161/CIRCULATIONAHA.106.177292., , , et al.